Last reviewed · How we verify

NCT06312891

Value of Heart Rate Lowering Therapy in Acute Myocarditis

Status unknown Last updated 15 March 2024
What this trial tests

trial testing Ivabradine in Myocarditis in 150 participants. Status unknown.

Timeline
1 April 2024
Primary endpoint
1 April 2025
1 June 2025

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment150
Start date1 April 2024
Primary completion1 April 2025
Estimated completion1 June 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 18 to 90, any sex, with Myocarditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the value of heart rate lowering therapy "pharmacological rest" on the short term in cases of myocarditis without LV dysfunction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A comparative review of myocarditis in pediatrics versus adults: pathogenesis, diagnosis, and management.
    Ricci JC, Farahani NA, Davis CJ, Ritter KG, et al · · 2025 · cited 2× · PMID 41080571 · DOI 10.3389/fimmu.2025.1601307

Verify or expand the search:

Other trials of Ivabradine

Trials testing the same drug.

Other recruiting trials for Myocarditis

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06312891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing